China Resources Pharmaceutical: Achieve total revenue of 269.574 billion yuan by 2025, completing multiple acquisition projects in biopharmaceuticals, traditional Chinese medicine, chemical drugs, and other fields.

LightningPacketLoss

2026-03-29 09:31:58

Abstract generation in progress

On March 25, China Resources Pharmaceutical released its performance announcement for the year ending December 31, 2025. The company achieved total revenue of 269.574 billion yuan, an increase of 4.6% compared to last year’s 257.673 billion yuan. Gross profit was 44.508 billion yuan, up 9.4% from last year’s 40.689 billion yuan, with an overall gross profit margin rising to 16.5%. Net profit was 9.653 billion yuan, an increase of 14.9% compared to 8.403 billion yuan in 2024; profit attributable to equity holders of the company was 4.045 billion yuan, up 20.7%.

During the reporting period, the Group completed multiple acquisition projects in the fields of biopharmaceuticals, traditional Chinese medicine, and chemical drugs, introduced several high-quality products, and established an industrial development fund to further enrich investment tools; in terms of technological innovation, it promoted the launch of new products, strengthened external collaborations, facilitated the implementation of several innovative consortia, and optimized product mix and business structure; in operational management, it focused on building an excellent operational system, continuously promoted cost reduction and efficiency improvement, and enhanced digital intelligence capabilities, receiving multiple industry honors; in supply chain construction, it strengthened upstream and downstream coordinated management, and the resilience and overall competitiveness of the supply chain continued to increase; in international expansion, it achieved registration and sales in multiple varieties and countries, further enhancing the influence of traditional Chinese medicine culture.

(China Resources Pharmaceutical Announcement)

(Editor: Yang Yan Lin Chen)

Keywords:

                                                            Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes